Fig. 2

Immunohistochemical (IHC) analysis showed PD-L1 was expressed in 20–30% of lung tumor cells of this patient (a, b) as compared with the positive control (c). The antibody of PD-L1 (VentanaSP263) was purchased from Roche, San Francisco, CA, USA)